Cancer Moonshot Gets a Boost From This AI-Driven Clinical Research Platform

The death of President Biden’s son due to brain cancer in 2015 inspired the Cancer Moonshot initiative. In 2019, Harsha Rajasimha, MS, PhD, was inspired to start Jeeva Clinical Trials because of a similar incident. He lost his baby to a rare disease. This tragic event ignited a desire to prevent such tragedies from devastating other families.

Driven by a proven and validated solution, Jeeva’s new Enterprise platform aims to accelerate clinical research for life-saving therapies for cancer, rare diseases, and chronic illnesses that is more inclusive of underserved communities.

DocWire News spoke with Dr. Rajasimha about his company’s platform, its relevance to the Cancer Moonshot initiative, and how Jeeva wants to revolutionize global cancer research.